Galenica Sante (Switzerland) Today
| GALE Stock | CHF 76.50 0.35 0.46% |
Performance7 of 100
| Odds Of DistressLess than 9
|
Galenica Sante is selling for under 76.50 as of the 26th of November 2024; that is 0.46 percent decrease since the beginning of the trading day. The stock's lowest day price was 76.45. Galenica Sante has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat ok performance during the last 90 days. Equity ratings for Galenica Sante AG are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of October 2024 and ending today, the 26th of November 2024. Click here to learn more.
Galenica AG operates as a healthcare provider in Switzerland and internationally. The company was incorporated in 2017 and is headquartered in Bern, Switzerland. Galenica Sant operates under Biotechnology classification in Switzerland and is traded on Switzerland Exchange. The company has 49.64 M outstanding shares. More on Galenica Sante AG
Moving against Galenica Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Galenica Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Galenica Sante's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Galenica Sante or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Galenica Sante AG (GALE) is traded on SIX Swiss Exchange in Switzerland and employs 5,517 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.74 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Galenica Sante's market, we take the total number of its shares issued and multiply it by Galenica Sante's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Galenica Sante AG operates under Healthcare sector and is part of Biotechnology industry. The entity has 49.64 M outstanding shares.
Galenica Sante AG has accumulated about 164.98 M in cash with 333.1 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.13.
Check Galenica Sante Probability Of Bankruptcy
Ownership AllocationGalenica Sante AG has a total of 49.64 Million outstanding shares. 30% of Galenica Sante AG outstanding shares are owned by outside corporations. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Galenica Ownership Details
Galenica Sante AG Risk Profiles
Although Galenica Sante's alpha and beta are two of the key measurements used to evaluate Galenica Sante's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.6567 | |||
| Semi Deviation | 0.5299 | |||
| Standard Deviation | 0.8556 | |||
| Variance | 0.732 |
Galenica Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Galenica Sante without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sectors Now
SectorsList of equity sectors categorizing publicly traded companies based on their primary business activities |
| All Next | Launch Module |
Galenica Sante Corporate Management
Elected by the shareholders, the Galenica Sante's board of directors comprises two types of representatives: Galenica Sante inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Galenica. The board's role is to monitor Galenica Sante's management team and ensure that shareholders' interests are well served. Galenica Sante's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Galenica Sante's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jrg Kneubhler | Advisor | Profile | |
| Marianne Ellenberger | Head HR | Profile | |
| Virginie Jeschka | Chief Officer | Profile | |
| Thomas Szuran | Chief Officer | Profile | |
| Daniele Madonna | Chief Officer | Profile | |
| Barbara Walchli | Gen Sec | Profile | |
| Christina Hertig | Head Communications | Profile |
Additional Tools for Galenica Stock Analysis
When running Galenica Sante's price analysis, check to measure Galenica Sante's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galenica Sante is operating at the current time. Most of Galenica Sante's value examination focuses on studying past and present price action to predict the probability of Galenica Sante's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galenica Sante's price. Additionally, you may evaluate how the addition of Galenica Sante to your portfolios can decrease your overall portfolio volatility.